Other headlinesSonoSite shows vascular products
Takeover talk drives Hologic stock
Wall Street is buzzing with rumors that Hologic is a takeover target. The rumors have helped drive share prices of the women’s health specialist from a year low of under $12 in early summer to nearly $18 this week. Best known in radiology circles for its digital mammography equipment, Hologic expanded into therapeutics and other women’s products two years ago through a merger with Cytec.
SonoSite shows vascular products
The pioneer of handheld ultrasound is extending its reach in point-of-care medicine with technologies that address patient safety and mobile power for its vascular access ultrasound tools. Bothell, WA-based SonoSite showcased the enhancements at its booth Sept. 14 to 18 during the Association for Vascular Access (AVA) meeting in Las Vegas. Headlining the vascular exhibits are the company’s six-pound NanoMaxx, which is pending FDA clearance, a hand-carried unit that combines one-button operation with a fluid resistant touch screen user interface; LumenVu Catheter Guidance System, which is designed to visualize the placement of peripherally inserted central catheters at the point-of-care; and universal stands that charge batteries onboard SonoSite’s M-Turbo, S Series, NanoMaxx and MicroMaxx product, when the hand-carried systems are docked to the stands.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.